ArticleBMC plant biology2025
Functional characterization of PcMYB25, a candidate regulator of Patchouli alcohol biosynthesis in Pogostemon cablin, via exogenous hormone-elicited transcriptome analysis.
Article in BMC plant biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundPlant hormones often cause changes in secondary metabolites. Patchouli alcohol (PA) is a bioactive compound of the medicinal plant Pogostemon cablin. Similar to other secondary metabolites, its synthesis is also regulated by transcription factors. While the PA biosynthetic pathway has been characterized, its regulatory mechanisms remain incompletely understood.
resultsTranscriptome analysis revealed that exogenous hormone application significantly altered the transcriptional landscape of Pogostemon cablin, particularly affecting genes involved in terpenoid metabolism. Through weighted gene co-expression network analysis (WGCNA), we identified the R2R3-MYB transcription factor gene PcMYB25 as a key candidate regulator. Transient overexpression analysis showed that overexpression of PcMYB25 significantly upregulated PcPTS expression and select upstream MVA pathway genes, and increased PA content by 85% compared to empty vector controls. In addition, yeast one-hybrid assays confirmed that PcMYB25 binds to the PcPTS promoter, and transcriptional activation assays demonstrated its strong transactivation activity.
conclusionsWe conclude that exogenous hormone treatment triggers an extensive transcriptional response in patchouli, and integrated co-expression analysis identifies PcMYB25 as a candidate regulatory factor involved in plant hormone signaling and the accumulation of PcPTS-derived PA and sesquiterpenoid compounds. These findings not only provide new insights into the transcriptional regulation of PA biosynthesis, but also lay the foundation for further genetic engineering strategies for PA production.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.